benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal and thiazolyl-blue

benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal has been researched along with thiazolyl-blue* in 1 studies

Other Studies

1 other study(ies) available for benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal and thiazolyl-blue

ArticleYear
Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines.
    Folia histochemica et cytobiologica, 2001, Volume: 39, Issue:2

    In this study we compared the sensitivity of different human and murine cell lines varying in the stage of transformation to dose- and time-dependent cytostatic and/or cytotoxic effects of PSI (a selective proteasome inhibitor), measured by a standard MTT assay. It was found that intensively proliferating cell lines were more sensitive to very small doses of PSI after 24 h incubation than the slow proliferating ones. Non-transformed cell lines showed no sensitivity to PSI, as there was no difference in cell viability in comparison with the control group even after 72 h incubation.

    Topics: Algorithms; Animals; Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cysteine Endopeptidases; Genes, ras; Humans; Mice; Multienzyme Complexes; Oligopeptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2001